Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Accessible nucleophilic groups on microbial biomolecules represent a broad class of reactive chemical sites, including sulfhydryl (-SH), amino (-NH2), and hydroxyl (-OH) groups, found on various microbial components such as proteins, enzymes, and nucleic acids (McDonnell & Russell, 1999). These groups are essential for the microbe's survival, playing key roles in metabolic catalysis and structural integrity. Many antimicrobial agents, including biocides like glutaraldehyde and heavy metals like silver, function as electrophiles that covalently bind to or oxidize these nucleophilic centers (StatPearls, 2023). This interaction leads to the cross-linking of proteins, inactivation of vital enzymes, and disruption of the microbial cell wall or genome, effectively neutralizing the pathogen. Because these nucleophilic groups are also present in human cells, drugs targeting them often lack high specificity, which typically restricts their use to topical applications or sterilization processes to avoid systemic toxicity (PubChem). Consequently, these groups are considered non-specific targets rather than precise therapeutic receptors, and their modification is a hallmark of broad-spectrum antiseptic action.
Electrophilic attack and covalent modification (alkylation, oxidation, or coordination) of nucleophilic groups such as thiols, amines, and hydroxyls, leading to the inactivation of essential microbial proteins and enzymes (McDonnell & Russell, 1999).
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Accessible nucleophilic groups on microbial biomolecules.